Press ESC to close

Peptide Lab App Log in Articles News Guide Products
More Peptide Tracker Calculator Best Calculators Peptide Statistics Contact Newsletter
Français English Deutsch Español Português العربية Italiano Polski 한국어 日本語 中文 Русский Nederlands Čeština Svenska Türkçe

Peptide Encyclopedia

Our encyclopedia of the most researched peptides. Mechanisms of action, studied benefits and research status for each peptide.

60 Guide
5-Amino-1MQ
Preclinical only (cell and rodent studies). No published human clinical trial.

5-Amino-1MQ

5-Amino-1-methylquinolinium (commonly supplied as the iodide salt)

Amycretin
Investigational. Early-phase and phase 2 data published; phase 3 trials under way since February 2026. Not approved by the FDA, the EMA or any other regulator.

Amycretin

Amycretin (international nonproprietary name: zenagamtide; development codes NNC0487-0111 / NN9487)

AOD-9604
Research peptide, not approved as a drug for human use

AOD-9604

Anti-Obesity Drug 9604 (Tyr-hGH 177-191 fragment)

ARA-290 (Cibinetide)
Investigational. Phase 2 trials completed, not approved by the FDA or the EMA.

ARA-290 (Cibinetide)

Cibinetide, pyroglutamate helix B surface peptide (pHBSP)

Argireline
Clinical Studies

Argireline

Acetyl Hexapeptide-8

BPC-157
Active Research

BPC-157

Body Protection Compound-157

Cagrilintide
Investigational. Not approved by the FDA or EMA. Phase 3 clinical development.

Cagrilintide

Cagrilintide (AM833, NNC0174-0833), long-acting acylated human amylin analogue

CagriSema
Investigational: phase 3 completed, under regulatory review, not approved

CagriSema

Cagrilintide and semaglutide fixed-dose combination

Cerebrolysin
Prescription medicine in some countries (Eastern Europe, Russia and the CIS, parts of Asia). Not approved by the FDA in the United States and no centralized EMA authorization. Not for self-administration.

Cerebrolysin

Low-molecular-weight peptide and free amino acid preparation derived from porcine brain protein (EVER Neuro Pharma)

Certificate of Analysis (CoA)
For research and educational use only, not approved for human use

Certificate of Analysis (CoA)

Peptide Certificate of Analysis: Quality Control Documentation

CJC-1295
Phase 1/2 trials, development halted (2006)

CJC-1295

Modified Growth Hormone Releasing Hormone

Dihexa (PNB-0408)
Preclinical only (animal studies); no published human clinical trial; not approved for human use

Dihexa (PNB-0408)

N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide